Exploring the nature of the interaction between human monoclonal antiphospholipid antibodies and domain I of ß2-glycoprotein I.

被引:0
|
作者
Pericleous, Charis
Ioannou, Yiannis
Lambrianides, Anastasia
Chen, Pojen
Latchman, David
Isenberg, David
Rahman, Anisur
Giles, Ian
机构
[1] UCL, London, England
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S559 / S560
页数:2
相关论文
共 50 条
  • [31] Pathophysiology of β2-glycoprotein I in antiphospholipid syndrome
    Matsuura, E.
    Shen, L.
    Matsunami, Y.
    Quan, N.
    Makarova, M.
    Geske, F. J.
    Boisen, M.
    Yasuda, S.
    Kobayashi, K.
    Lopez, L. R.
    LUPUS, 2010, 19 (04) : 379 - 384
  • [32] Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome
    Mondejar, R.
    Gonzalez-Rodriguez, C.
    Toyos-Saenz de Miera, F. J.
    Melguizo-Madrid, E.
    Zohoury, N.
    Mahler, M.
    Romero Losquino, I.
    Fabiani, F.
    CLINICA CHIMICA ACTA, 2014, 431 : 174 - 178
  • [33] Erratum to: Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    T. M. Reshetnyak
    F. A. Cheldieva
    M. V. Cherkasova
    S. I. Glukhova
    A. M. Lila
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 513 (1) : 358 - 358
  • [34] ANTIPHOSPHOLIPID ANTIBODIES AGAINST β-2 GLYCOPROTEIN I DOMAIN I IN ANTIPHOSPHOLIPID SYNDROME: ASSESSMENT BY CHEMOLUMINESCENCE
    Mauricio, A.
    Gonzalez, V.
    Marco, A.
    Puig, J.
    Marco, P.
    THROMBOSIS RESEARCH, 2014, 133 : S36 - S37
  • [35] ANTIBODIES AGAINST DOMAIN I OF β2 GLYCOPROTEIN I IN ANTIPHOSPHOLIPID ANTIBODY SYNDROME
    Chighizola, Cecilia
    Pregnolato, Francesca
    Grossi, Claudia
    Gerosa, Maria
    Norman, Gary
    Mahler, Michael
    Borghi, Maria Orietta
    Meroni, Pier Luigi
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A31 - A32
  • [36] Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S.
    Kveder, T.
    Artenjak, A.
    Gallova, Z. Ulcova
    Swadzba, J.
    Musial, J.
    Iwaniec, T.
    Stojanovich, L.
    Alessandri, C.
    Valesini, G.
    Avcin, T.
    Tervaert, J. W. Cohen
    Rozman, B.
    Bozic, B.
    LUPUS, 2012, 21 (07) : 764 - 765
  • [37] Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss:: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro
    Di Simone, N
    Raschi, E
    Testoni, C
    Castellani, R
    D'Asta, M
    Shi, T
    Krilis, SA
    Caruso, A
    Meroni, PL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) : 462 - 467
  • [38] Effects of β2-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis
    Ieko, M
    Ichikawa, K
    Atsumi, T
    Takeuchi, R
    Sawada, KI
    Yasukouchi, T
    Koike, T
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (01): : 85 - 90
  • [39] β2-glycoprotein I and anti-β2-glycoprotein I antibodies:: Where are we now?
    Inanç, M
    Radway-Bright, EL
    Isenberg, DA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (12): : 1247 - 1257
  • [40] Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome:: lack of association with anti-β2-glycoprotein I antibodies
    Swadzba, J
    Sanak, M
    Iwaniec, T
    Dziedzina, S
    Musial, J
    LUPUS, 2006, 15 (04) : 218 - 222